{
    "info": {
        "nct_id": "NCT03941769",
        "official_title": "A Phase I/II Study of Recombinant Human Interleukin-7 to Promote T-Cell Recovery After Haploidentical and Cord Blood Stem Cell Transplantation",
        "inclusion_criteria": "* English and non-English speaking patients are eligible.\n* Patient post a cord blood transplant (CBT) or haplo-SCT, with matched unrelated donors (MUDs), both peripheral blood (PB) and marrow sources with documented absolute neutrophil engraftment\n* Patients with documented engraftment but require granulocyte-colony stimulating factor (G-CSF) to treat myelosuppression induced by drugs used to treat or prevent infection are eligible\n* Karnofsky performance status (KPS) > 60%\n* Absence of dyspnea or hypoxia (< 90% of saturation by pulse oximetry on room air)\n* Bilirubin =< 1.5 x upper limit of normal (ULN)\n* Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) and/or alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x ULN\n* Prothrombin time (PT)/partial prothrombin time (PTT) < 1.5 x ULN\n* Calculated creatinine clearance > 60 mL/min/1.73 m^2\n* Diagnosis of acute myeloid leukemia; myelodysplastic syndrome; chronic myeloid leukemia; myelofibrosis or myeloproliferative disease\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Pregnant or nursing\n* History of lymphoid malignancy (including Hodgkin disease, non-Hodgkin lymphoma, acute lymphoblastic leukemia and chronic lymphocytic leukemia) or acute biphenotypic leukemia\n* Patients with acute GVHD > grade 2 at any time during the post-transplant course\n* Ongoing immunosuppressive therapy for the treatment of GVHD. Patients receiving GVHD prophylaxis will be allowed on this study\n* History of Epstein-Barr virus (EBV) associated lymphoproliferation\n* Active uncontrolled viral, bacterial or fungal infection\n* History of autoimmune disease\n* Receiving systemic corticosteroid therapy, budesonide is allowed\n* Uncontrolled hypertension\n* Corrected QT (QTc) prolongation (QTc > 470 ms) or prior history of significant arrhythmia or electrocardiogram (ECG) abnormalities\n* Active drug or alcohol use or dependence that, in the opinion of the investigator, would interfere with adherence to study requirements\n* Patients with cognitive impairments and/or any past or current psychiatric illness that, in the opinion of the investigator, would interfere with adherence to study requirements or the ability and willingness to give written informed consent",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Karnofsky performance status (KPS) > 60%",
            "criterions": [
                {
                    "exact_snippets": "Karnofsky performance status (KPS) > 60%",
                    "criterion": "Karnofsky performance status (KPS)",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">",
                                "value": 60,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) and/or alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x ULN",
            "criterions": [
                {
                    "exact_snippets": "Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) ... =< 2.5 x ULN",
                    "criterion": "aspartate aminotransferase (AST) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) ... =< 2.5 x ULN",
                    "criterion": "alanine aminotransferase (ALT) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diagnosis of acute myeloid leukemia; myelodysplastic syndrome; chronic myeloid leukemia; myelofibrosis or myeloproliferative disease",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of acute myeloid leukemia",
                    "criterion": "acute myeloid leukemia",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Diagnosis of ... myelodysplastic syndrome",
                    "criterion": "myelodysplastic syndrome",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Diagnosis of ... chronic myeloid leukemia",
                    "criterion": "chronic myeloid leukemia",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Diagnosis of ... myelofibrosis",
                    "criterion": "myelofibrosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Diagnosis of ... myeloproliferative disease",
                    "criterion": "myeloproliferative disease",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Calculated creatinine clearance > 60 mL/min/1.73 m^2",
            "criterions": [
                {
                    "exact_snippets": "Calculated creatinine clearance > 60 mL/min/1.73 m^2",
                    "criterion": "calculated creatinine clearance",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 60,
                                "unit": "mL/min/1.73 m^2"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Bilirubin =< 1.5 x upper limit of normal (ULN)",
            "criterions": [
                {
                    "exact_snippets": "Bilirubin =< 1.5 x upper limit of normal (ULN)",
                    "criterion": "bilirubin level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prothrombin time (PT)/partial prothrombin time (PTT) < 1.5 x ULN",
            "criterions": [
                {
                    "exact_snippets": "Prothrombin time (PT) ... < 1.5 x ULN",
                    "criterion": "prothrombin time (PT)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "partial prothrombin time (PTT) < 1.5 x ULN",
                    "criterion": "partial prothrombin time (PTT)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* English and non-English speaking patients are eligible.",
            "criterions": [
                {
                    "exact_snippets": "English and non-English speaking patients are eligible.",
                    "criterion": "language proficiency",
                    "requirements": [
                        {
                            "requirement_type": "language",
                            "expected_value": [
                                "English",
                                "non-English"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients with documented engraftment but require granulocyte-colony stimulating factor (G-CSF) to treat myelosuppression induced by drugs used to treat or prevent infection are eligible",
            "criterions": [
                {
                    "exact_snippets": "Patients with documented engraftment",
                    "criterion": "engraftment",
                    "requirements": [
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "require granulocyte-colony stimulating factor (G-CSF) to treat myelosuppression induced by drugs used to treat or prevent infection",
                    "criterion": "requirement for granulocyte-colony stimulating factor (G-CSF)",
                    "requirements": [
                        {
                            "requirement_type": "necessity for G-CSF due to myelosuppression induced by drugs used to treat or prevent infection",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Absence of dyspnea or hypoxia (< 90% of saturation by pulse oximetry on room air)",
            "criterions": [
                {
                    "exact_snippets": "Absence of dyspnea",
                    "criterion": "dyspnea",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "hypoxia (< 90% of saturation by pulse oximetry on room air)",
                    "criterion": "hypoxia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "oxygen saturation",
                            "expected_value": {
                                "operator": "<",
                                "value": 90,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patient post a cord blood transplant (CBT) or haplo-SCT, with matched unrelated donors (MUDs), both peripheral blood (PB) and marrow sources with documented absolute neutrophil engraftment",
            "criterions": [
                {
                    "exact_snippets": "Patient post a cord blood transplant (CBT) or haplo-SCT, with matched unrelated donors (MUDs), both peripheral blood (PB) and marrow sources",
                    "criterion": "hematopoietic stem cell transplant type",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "cord blood transplant (CBT)",
                                "haploidentical stem cell transplant (haplo-SCT)",
                                "matched unrelated donor (MUD) transplant from peripheral blood (PB)",
                                "matched unrelated donor (MUD) transplant from marrow"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "documented absolute neutrophil engraftment",
                    "criterion": "absolute neutrophil engraftment",
                    "requirements": [
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Patients with cognitive impairments and/or any past or current psychiatric illness that, in the opinion of the investigator, would interfere with adherence to study requirements or the ability and willingness to give written informed consent",
            "criterions": [
                {
                    "exact_snippets": "cognitive impairments",
                    "criterion": "cognitive impairment",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "any past or current psychiatric illness",
                    "criterion": "psychiatric illness",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "would interfere with adherence to study requirements",
                    "criterion": "ability to adhere to study requirements",
                    "requirements": [
                        {
                            "requirement_type": "interference",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "ability and willingness to give written informed consent",
                    "criterion": "ability and willingness to give written informed consent",
                    "requirements": [
                        {
                            "requirement_type": "ability and willingness",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients with acute GVHD > grade 2 at any time during the post-transplant course",
            "criterions": [
                {
                    "exact_snippets": "acute GVHD > grade 2 at any time during the post-transplant course",
                    "criterion": "acute GVHD",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "grade"
                            }
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at any time during the post-transplant course"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of autoimmune disease",
            "criterions": [
                {
                    "exact_snippets": "History of autoimmune disease",
                    "criterion": "autoimmune disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Receiving systemic corticosteroid therapy, budesonide is allowed",
            "criterions": [
                {
                    "exact_snippets": "Receiving systemic corticosteroid therapy",
                    "criterion": "systemic corticosteroid therapy",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "budesonide is allowed",
                    "criterion": "budesonide use",
                    "requirements": [
                        {
                            "requirement_type": "allowance",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of lymphoid malignancy (including Hodgkin disease, non-Hodgkin lymphoma, acute lymphoblastic leukemia and chronic lymphocytic leukemia) or acute biphenotypic leukemia",
            "criterions": [
                {
                    "exact_snippets": "History of lymphoid malignancy (including Hodgkin disease, non-Hodgkin lymphoma, acute lymphoblastic leukemia and chronic lymphocytic leukemia)",
                    "criterion": "history of lymphoid malignancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "acute biphenotypic leukemia",
                    "criterion": "history of acute biphenotypic leukemia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active uncontrolled viral, bacterial or fungal infection",
            "criterions": [
                {
                    "exact_snippets": "Active uncontrolled viral ... infection",
                    "criterion": "viral infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "Active uncontrolled ... bacterial ... infection",
                    "criterion": "bacterial infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "Active uncontrolled ... fungal infection",
                    "criterion": "fungal infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Corrected QT (QTc) prolongation (QTc > 470 ms) or prior history of significant arrhythmia or electrocardiogram (ECG) abnormalities",
            "criterions": [
                {
                    "exact_snippets": "Corrected QT (QTc) prolongation (QTc > 470 ms)",
                    "criterion": "QTc interval",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 470,
                                "unit": "ms"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "prior history of significant arrhythmia",
                    "criterion": "significant arrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "electrocardiogram (ECG) abnormalities",
                    "criterion": "electrocardiogram (ECG) abnormalities",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active drug or alcohol use or dependence that, in the opinion of the investigator, would interfere with adherence to study requirements",
            "criterions": [
                {
                    "exact_snippets": "Active drug or alcohol use or dependence",
                    "criterion": "drug or alcohol use or dependence",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "in the opinion of the investigator, would interfere with adherence to study requirements",
                    "criterion": "likelihood of adherence to study requirements",
                    "requirements": [
                        {
                            "requirement_type": "investigator opinion of interference",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of Epstein-Barr virus (EBV) associated lymphoproliferation",
            "criterions": [
                {
                    "exact_snippets": "History of Epstein-Barr virus (EBV) associated lymphoproliferation",
                    "criterion": "Epstein-Barr virus (EBV) associated lymphoproliferation",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled hypertension",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled hypertension",
                    "criterion": "hypertension",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ongoing immunosuppressive therapy for the treatment of GVHD. Patients receiving GVHD prophylaxis will be allowed on this study",
            "criterions": [
                {
                    "exact_snippets": "Ongoing immunosuppressive therapy for the treatment of GVHD",
                    "criterion": "immunosuppressive therapy for GVHD",
                    "requirements": [
                        {
                            "requirement_type": "ongoing use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnant or nursing",
            "criterions": [
                {
                    "exact_snippets": "Pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "nursing",
                    "criterion": "nursing status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}